1. Home
  2. LASR vs PHAR Comparison

LASR vs PHAR Comparison

Compare LASR & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • PHAR
  • Stock Information
  • Founded
  • LASR 2000
  • PHAR 1988
  • Country
  • LASR United States
  • PHAR Netherlands
  • Employees
  • LASR N/A
  • PHAR N/A
  • Industry
  • LASR Semiconductors
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • PHAR Health Care
  • Exchange
  • LASR Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • LASR 541.0M
  • PHAR 624.1M
  • IPO Year
  • LASR 2018
  • PHAR N/A
  • Fundamental
  • Price
  • LASR $10.03
  • PHAR $8.86
  • Analyst Decision
  • LASR Strong Buy
  • PHAR Strong Buy
  • Analyst Count
  • LASR 4
  • PHAR 3
  • Target Price
  • LASR $15.13
  • PHAR $27.00
  • AVG Volume (30 Days)
  • LASR 317.9K
  • PHAR 5.9K
  • Earning Date
  • LASR 02-27-2025
  • PHAR 03-13-2025
  • Dividend Yield
  • LASR N/A
  • PHAR N/A
  • EPS Growth
  • LASR N/A
  • PHAR N/A
  • EPS
  • LASR N/A
  • PHAR N/A
  • Revenue
  • LASR $203,059,000.00
  • PHAR $285,745,000.00
  • Revenue This Year
  • LASR N/A
  • PHAR $20.08
  • Revenue Next Year
  • LASR $7.61
  • PHAR $9.22
  • P/E Ratio
  • LASR N/A
  • PHAR N/A
  • Revenue Growth
  • LASR N/A
  • PHAR 30.64
  • 52 Week Low
  • LASR $9.15
  • PHAR $6.65
  • 52 Week High
  • LASR $14.73
  • PHAR $12.20
  • Technical
  • Relative Strength Index (RSI)
  • LASR 40.02
  • PHAR 48.50
  • Support Level
  • LASR $10.74
  • PHAR $8.50
  • Resistance Level
  • LASR $11.09
  • PHAR $9.50
  • Average True Range (ATR)
  • LASR 0.50
  • PHAR 0.56
  • MACD
  • LASR -0.09
  • PHAR 0.03
  • Stochastic Oscillator
  • LASR 16.00
  • PHAR 58.71

About LASR nLIGHT Inc.

nLight Inc is a United States-based company engaged in providing semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. It designs, develops and manufactures the critical elements of lasers, through its vertically integrated business model to rapidly introduce innovative products, control costs and protect intellectual property. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, China, and the Rest of the world.

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Share on Social Networks: